Click here for Eliquis® (apixaban) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Eliquis (apixaban) is an oral, direct factor Xa inhibitor indicated for prevention of stroke / systemic embolism in adult patients with NVAF, with one or more risk factors (such as prior stroke or transient ischaemic attack, age ≥ 75 years, hypertension, diabetes mellitus, symptomatic heart failure [NYHA Class ≥ II]), treatment of DVT and PE, and prevention of recurrent DVT and PE in adults.1
Access materials to support your Eliquis patients for:
Find out more about the use of Eliquis in AF
Find out more about the use of Eliquis in DVT/PE
Visit Masterclass TV to watch on demand content, discussing patient case studies, specifically designed to educate, motivate and inspire clinical excellence in management of anticoagulation.
** This is an optional area where footnotes can live.
Tune in to Horizon TV to watch LIVE clinical webinars, discussing challenging patient case studies, all designed for consolidating best practice for healthcare professionals.
** This is an optional area where footnotes can live.
BD = Twice Daily
DVT = Deep Vein Thrombosis
NVAF = Non-Valvular Atrial Fibrillation
PE = Pulmonary Embolism
SmPC = Summary of Product Characteristics
Reference:
1. Eliquis (apixaban) Summary of Product Characteristics www.medicines.org.uk/emc
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
No
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?